Abstract
Building a cost-effectiveness model in the ophthalmology disease area is challenging due to the ambiguity of utility estimates that comes from the bilateral nature of the disease. With the availability of a recent study that provides utility estimates accounting for the bilateral nature of vision, we evaluated the impact of different utility values on a cost-effectiveness model in diabetic macular edema.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Paper Title
Journal
Date
